Hochschulschrift
Assessment of neuroprotective effects of gamma-hydroxybutyrate and neurosteroids on cellular models of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Saarbrücken, Universität des Saarlandes, Diss., 2014
- Schlagwort
-
Alzheimer-Krankheit ; Apoptosis ; Hydroxybuttersäure ; Steroide ; Nervensystem
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Saarbrücken
- (wer)
-
Saarländische Universitäts- und Landesbibliothek
- (wann)
-
2014
- Urheber
-
Wendt, Guillaume
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bsz:291-scidok-59369
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Wendt, Guillaume
- Schmitt, Manfred J.
- Saarländische Universitäts- und Landesbibliothek
Entstanden
- 2014
Ähnliche Objekte (12)
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology
![Induction of a neuroprotective phenotype of macrophages by the β-hydroxybutyrate [beta-hydroxybutyrate] receptor HCA2](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Induction of a neuroprotective phenotype of macrophages by the β-hydroxybutyrate [beta-hydroxybutyrate] receptor HCA2
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
Evaluating the neuroprotective effect of Spirulina platensis–loaded niosomes against Alzheimer’s disease induced in rats
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
Neuroprotective effects of Cubebin and Hinokinin lignan fractions of Piper cubeba fruit in Alzheimer’s disease in vitro model
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology
Induction of a neuroprotective phenotype of macrophages by the β-hydroxybutyrate [beta-hydroxybutyrate] receptor HCA2
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
Evaluating the neuroprotective effect of Spirulina platensis–loaded niosomes against Alzheimer’s disease induced in rats
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
Neuroprotective effects of Cubebin and Hinokinin lignan fractions of Piper cubeba fruit in Alzheimer’s disease in vitro model
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology
Induction of a neuroprotective phenotype of macrophages by the β-hydroxybutyrate [beta-hydroxybutyrate] receptor HCA2
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
Evaluating the neuroprotective effect of Spirulina platensis–loaded niosomes against Alzheimer’s disease induced in rats
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models